Protein-energy malnutrition during pregnancy alters caffeine's effect on brain tissue of neonate rats.
We studied whether protein-energy malnutrition changed brain susceptibility to a small dose of caffeine in newborn rats. Since we had demonstrated previously that caffeine intake during lactation increased the brain neuropeptide on newborns, we investigated further the effects of the prenatal administration of caffeine on TRH and cyclo (His-Pro). From day 13 of gestation to delivery day, pregnant rats in one group were fed either a 20% or a 6% protein diet ad libitum, and those in the other group were pair-fed with each protein diet supplemented with caffeine at an effective dose of 2 mg/100 g body weight. Upon delivery, brain weight, brain protein, RNA, DNA and the neuropeptides thyrotropin-releasing hormone (TRH) and cyclo (His-Pro) were measured in the newborn rats. A 6% protein without caffeine diet caused reductions in brain weights and brain protein, RNA and DNA contents, but did not alter brain TRH and cyclo (His-Pro) concentrations in the newborn animals. In the offspring from dams fed a 6% protein diet, caffeine administration significantly elevated brain weights and brain contents of protein, RNA and DNA. In contrast, these values were similar between noncaffeine and caffeine-supplemented animals in a 20% protein diet group. Brain TRH and cyclo (His-Pro) concentrations were not changed by caffeine administration. These data suggest that caffeine augments protein synthesis in the newborn rat brain when malnourished, but that the same dose of caffeine did not affect protein synthesis in brains of newborn rats from normally nourished dams. Therefore, the present findings indicate that the nutritional status of mothers during pregnancy has important implication in the impact of caffeine on their offspring's brains.
D000328:Adult; D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D002110:Caffeine / Q000494:pharmacology*; D004247:DNA / Q000032:analysis; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007223:Infant; D009419:Nerve Tissue Proteins / Q000032:analysis; D009929:Organ Size / Q000187:drug effects; D010456:Peptides, Cyclic / Q000032:analysis; D010879:Piperazines / Q000032:analysis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000378:metabolism*; D011502:Protein-Energy Malnutrition / Q000378:metabolism*; D012313:RNA / Q000032:analysis; D051381:Rats; D013973:Thyrotropin-Releasing Hormone / Q000032:analysis
D009419:Nerve Tissue Proteins; D010456:Peptides, Cyclic; D010879:Piperazines; D002110:Caffeine; D013973:Thyrotropin-Releasing Hormone; D012313:RNA; D004247:DNA; C015924:histidyl-proline diketopiperazine